Warsaw 29 October 2007 1

Pharmaceutical Pricing & Reimbursement Information ÖBIG

Price Volume AgreementsPPRI Project

Christine LeopoldGesundheit Österreich GmbH

PPRI ConferenceWarsaw, 29 October 2007

Warsaw 29 October 2007 2

Pharmaceutical Pricing & Reimbursement Information ÖBIG

Pricing policies

Price control (statutory pricing, price negotiation,public procurement)

Free pricing

Pricing procedures External price referencing

Internal price referencing

Cost-plus

Others (e.g. indirect price control)

Terminology regarding pricing

Warsaw 29 October 2007 3

Pharmaceutical Pricing & Reimbursement Information ÖBIG

For all pharmaceuticals (BE, BG, CY, CZ, EL, LU; TR)

For POM (NL, PT; NO)

For reimbursable pharmaceuticals

Most common pricing policy

No price control DK - however linkage to reimbursement

MT

Pricing policiesPrice control (at price setting level)

Warsaw 29 October 2007 4

Pharmaceutical Pricing & Reimbursement Information ÖBIG

Statutory pricing e.g. BE, BG, CY, CZ, EL, ES, LT, LU, PT, SE; NO, TR

Negotiations (FR, IT)

Mixture

Statutory pricing after negotiations (EE, LV, PL)

Price Volume Agreements (e.g. EE)

Public procurement in the hospital sector

Pricing policiesWay of price control

Warsaw 29 October 2007 5

Pharmaceutical Pricing & Reimbursement Information ÖBIG

Claw-back A system allowing third party payers to recoup (part of the)

discounts/rebates granted in a reimbursement system between various stakeholders, e.g. wholesalers and pharmacists

Examples are NL and UK

Pay-back A financial mechanism that requires manufacturers to refund a

part of their revenue to a payer (i.g. social health insurance / national health service) if sales exceed a previously determined or agreed target-budget.

Example FR

Other ways of control costs